Earth Science Tech Inc. (OTC: ETST), a strategic healthcare-oriented holding company, reported a series of operational milestones in its fiscal year ended March 31, 2026, underscoring a transformation that has reshaped the company from a wellness-focused enterprise into a diversified holding company centered on healthcare, pharmaceutical compounding, telemedicine, real estate, and cash-flow-generating operating businesses.
In its annual shareholder letter, management highlighted that the company repurchased and retired more than 6.9 million shares of common stock since fiscal Q1 2026, reflecting a focus on reducing share dilution to support shareholder value. The ongoing share repurchase strategy has become a defining element of ETST's capital allocation approach, according to the company. The full letter is available at https://ibn.fm/WX3CI.
Key operating businesses, including DOConsultation, Villas Health, and MOC Teledoc, are now cash-flow positive, marking a significant operational milestone. Additionally, Peaks Curative surpassed $2 million in revenue during the first week of fiscal Q4 2026, reflecting growth within the company's health and wellness segment. Management emphasized that all expansion initiatives were completed without adding debt to the balance sheet, maintaining a disciplined capital structure.
CEO and Chairman Giorgio R. Saumat described fiscal 2026 as a year in which the company strengthened the foundation for future growth while remaining debt-free. Investors will have an opportunity to hear directly from management when Saumat presents at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17.
The transformation and operational progress are important for investors because they demonstrate Earth Science Tech's ability to generate cash flow across multiple business lines while actively reducing share dilution. The debt-free expansion strategy positions the company to pursue further growth without the burden of interest expenses, potentially enhancing long-term shareholder value. The share repurchase program directly benefits existing shareholders by increasing their proportional ownership, and the cash-flow positive status of key subsidiaries suggests sustainable operations. As the company continues to execute its strategy, stakeholders will be watching for sustained revenue growth from Peaks Curative and further expansion of its healthcare platform.
